Drugs Information: Satralizumab
Basic Information
|
||
| ID | DDInter1644 | |
| Drug Type | biotech | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| Description | Satralizumab is a subcutaneously injected anti-IL-6 receptor monoclonal antibody for the treatment of neuromyelitis optica spectrum disorder (NMOSD). | |
| ATC Classification | - | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Satralizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|